India defers roll out of IFRS 17 equivalent indefinitely: report
October 3 2024 by InsuranceAsia News-
India extends IFRS 17 implementation deadline to April 2027: report
- October 17
IRDAI had earlier set an April 2025 deadline for the implementation of the new accounting regime in the insurance sector.
-
IFRS 17: Making your financial controls automation truly work for you
- September 26
Shifting towards a more automated and streamlined workstream can free up time for insurers to critically analyse results that inform future financial planning.
-
Korean insurers may face bigger corporate tax bill this year due to IFRS: report
- May 15
The implementation of IFRS 17 means that the amount of cash surrender reserves recognised as expenses has surged by trillions of won per annum, according to a local report.
-
Exit-bound Lotte Insurance owner shopping for overseas private equity buyers: report
- April 18
South Korea’s JKL Partners is reportedly in talks with JC Flowers to sell the Korean non-life carrier in a sale process run by JPMorgan.ts valuation.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.